A drug called Galvus, will be helping the type 2 diabetes patients in keeping a tab of their blood sugar levels. At present, only a third of all the type 2 diabetes patients are able to reach their blood sugar level targets, the new drug would perhaps increase the number.
Dr. Neale Cohen of Melbourne's Baker Institute has said that the drug would help to reduce the blood sugar levels. The drug depends on glucose and will be on Pharmaceutical Benefit Scheme from the next month itself. The new medicine will not have common side effects, which are very usual in the cases of other drugs for diabetes type 2.
"If your glucose level is high, it has a very strong action if your glucose level is low its action is very small and that's quite an advantage”, said Dr. Cohen.
There are nearly 1.5 million type 2 diabetes patients in Australia. In type 2 diabetes, the insulin is not able to move glucose from the blood stream into the liver and body cells. Because of this insufficiency of glucose, the blood sugar level of the patient tends to be high.
A patient will have to take the pill once or twice in a day.
The drug was permitted to be used in the EU by the European Medicines Agency in Feb 2008. Though, it still has to get an approval in the U. S
- Gentle Electrical Stimulation May Help in Improving Maths Skills
- Mutated BRCA1 Gene Increases Breast Cancer Risk
- Research Finds Huge Increase in Type-2 Diabetes, Under-40 Hardest Hit
- Step Forward in IVF Treatment in 30 Can Mount up Baby Production Three-times
- David Cameron Blamed for ‘Scaremongering’ Over Health Tourism